Paediatric Ards Neuromuscular Blockade Study

NCT02902055 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped COVID-19, slow enrolment

Conditions

ARDS

Interventions

DRUG: Neuromuscular Blocking Agents
DRUG: Isotonic saline

Sponsor

University Medical Center Groningen